# American Hospital 2 Kosovo: Phase 3 study withdrawn (Infertility, Female)

**Score:** 65/100

| Field | Value |
|---|---|
| Sponsor | American Hospital 2 Kosovo |
| Sponsor type | Academic and hospital |
| Study | 150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE Trial |
| NCT ID | NCT07346235 |
| Phase | Phase 3 |
| Status | withdrawn |
| Conditions | Infertility, Female |
| Intervention types | drug |
| Posted | 2026-01-16 |
| Planned start | 2026-03-01 |
| Event | Withdrawn before enrolling |
| Event date | 2026-10-29 |
| Last update posted | 2026-10-29 |

## Why this score
- Posted in the last two weeks.
- Stopped early: budget and sites freed up.
- Phase 3: multi-site, larger budget.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07346235). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.